No Data
No Data
No Data
No Data
No Data
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference
HAYWARD, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or the "Company"), a clinical-stage, gene therapy-focused, biotechnology company developing novel g
GlobeNewswireMay 1 08:00 ET
Express News | Suvretta Capital Management LLC Reports a Stake of 19.99% in Benitec Biopharma as of April 22, 2024
ReutersApr 29 16:12 ET
Express News | Benitec Biopharma 13G Filing Shows Steven Oliveira Reported A 8.89% Passive Stake In The Co As Of April 22
BenzingaApr 29 11:48 ET
Express News | Steven Oliveira Reports 8.89% Passive Stake in Benitec Biopharma Inc as of April 22 - SEC Filing
ReutersApr 29 11:46 ET
JMP Securities Maintains Market Outperform on Benitec Biopharma, Raises Price Target to $16
JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma with a Market Outperform and raises the price target from $10 to $16.
Analyst UpgradesApr 22 12:17 ET
Benitec Biopharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/22/2024 128.57% JMP Securities $10 → $16 Maintains Market Outperform 02/15/2024 42.86% JMP Securities $
BenzingaApr 22 12:16 ET
2deMoonmoon : what does it mean
TrytosaveabitOP 2deMoonmoon: Means someone gave them 40 million without having to do a public offering! And now the company has more cash without have to borrow it
2deMoonmoon TrytosaveabitOP: oh wow. thanks for the explanation
TrytosaveabitOP 2deMoonmoon: You’re welcome
No Data
No Data